Skip to main content

ADVERTISEMENT

Alina Markova, MD

Alina Markova, MD, Memorial Sloan Kettering
Conference Coverage
01/11/2024
At the 65th ASH Annual Meeting in San Diego, California, Alina Markova, MD, shared study results that demonstrated ruxolitinib 1.5% cream was safe and effective compared to placebo in treating cutaneous nonsclerotic and superficially...
At the 65th ASH Annual Meeting in San Diego, California, Alina Markova, MD, shared study results that demonstrated ruxolitinib 1.5% cream was safe and effective compared to placebo in treating cutaneous nonsclerotic and superficially...
At the 65th ASH Annual Meeting...
01/11/2024
Oncology